APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chinese Medicine Reference Substance (CMRS)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chinese Medicine Reference Substance (CMRS) Market Outlook and Growth Opportunities 2026

23 December 2025194 pages

Choose your research edition.

Industry ResearchChinese Medicine Reference Substance (CMRS) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Chinese Medicine Reference Substance (CMRS) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Chinese Medicine Reference Substance (CMRS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chinese Medicine Reference Substance (CMRS) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Chinese Medicine Reference Substance (CMRS) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Chinese Medicine Reference Substance (CMRS) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chinese Medicine Reference Substance (CMRS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chinese Medicine Reference Substance (CMRS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chinese Medicine Reference Substance (CMRS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chinese Medicine Reference Substance (CMRS) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chinese Medicine Reference Substance (CMRS) market include Baoji Herbest Bio-Tech, ChemFaces, ChromaDex, Diagnocine, PhytoLab, Derick, Desite, GeLiPuBio and Chengdu Must Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chinese Medicine Reference Substance (CMRS) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chinese Medicine Reference Substance (CMRS) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chinese Medicine Reference Substance (CMRS) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chinese Medicine Reference Substance (CMRS) market size, projected growth trends, production technologies, key applications, and end-use industries.

Chinese Medicine Reference Substance (CMRS) Segment by Company

Baoji Herbest Bio-Tech

ChemFaces

ChromaDex

Diagnocine

PhytoLab

Derick

Desite

GeLiPuBio

Chengdu Must Biotechnology

Purechemland

Nature Standard

RENI Pharmaceutical Technology

Chinese Medicine Reference Substance (CMRS) Segment by Type

Plant-Derived Reference Substances

Mineral-Derived Reference Substances

Chemically Synthesized Reference Substances

Animal-Derived Reference Substances

Chinese Medicine Reference Substance (CMRS) Segment by Application

Pharmaceutical Identification

Pharmaceutical Development

Chinese Medicine Reference Substance (CMRS) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chinese Medicine Reference Substance (CMRS) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Chinese Medicine Reference Substance (CMRS) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chinese Medicine Reference Substance (CMRS) significant trends, drivers, influence factors in global and regions.

6. To analyze Chinese Medicine Reference Substance (CMRS) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Reference Substance (CMRS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Reference Substance (CMRS) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Reference Substance (CMRS).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chinese Medicine Reference Substance (CMRS) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chinese Medicine Reference Substance (CMRS) industry.

Chapter 3: Detailed analysis of Chinese Medicine Reference Substance (CMRS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Chinese Medicine Reference Substance (CMRS) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Chinese Medicine Reference Substance (CMRS) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chinese Medicine Reference Substance (CMRS) Industry Trends Table 2. Chinese Medicine Reference Substance (CMRS) Industry Drivers Table 3. Chinese Medicine Reference Substance (CMRS) Industry Opportunities and Challenges Table 4. Chinese Medicine Reference Substance (CMRS) Industry Restraints Table 5. Global Chinese Medicine Reference Substance (CMRS) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chinese Medicine Reference Substance (CMRS) Revenue Share by Company (2021-2026) Table 7. Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Company (k units) & (2021-2026) Table 8. Global Chinese Medicine Reference Substance (CMRS) Sales Volume Share by Company (2021-2026) Table 9. Global Chinese Medicine Reference Substance (CMRS) Average Price (USD/unit) of Company (2021-2026) Table 10. Global Chinese Medicine Reference Substance (CMRS) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Chinese Medicine Reference Substance (CMRS) Key Company Manufacturing Base & Headquarters Table 12. Global Chinese Medicine Reference Substance (CMRS) Company, Product Type & Application Table 13. Global Chinese Medicine Reference Substance (CMRS) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Chinese Medicine Reference Substance (CMRS) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plant-Derived Reference Substances Table 18. Significant Companies of Mineral-Derived Reference Substances Table 19. Significant Companies of Chemically Synthesized Reference Substances Table 20. Significant Companies of Animal-Derived Reference Substances Table 21. Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Type (2021-2026) & (k units) Table 23. Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Type (2027-2032) & (k units) Table 24. Global Chinese Medicine Reference Substance (CMRS) Sales Volume Share by Type (2021-2026) Table 25. Global Chinese Medicine Reference Substance (CMRS) Sales Volume Share by Type (2027-2032) Table 26. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type (2021-2026) Table 30. Global Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pharmaceutical Identification Table 32. Significant Companies of Pharmaceutical Development Table 33. Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Application (2021-2026) & (k units) Table 35. Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Application (2027-2032) & (k units) Table 36. Global Chinese Medicine Reference Substance (CMRS) Sales Volume Share by Application (2021-2026) Table 37. Global Chinese Medicine Reference Substance (CMRS) Sales Volume Share by Application (2027-2032) Table 38. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application (2021-2026) Table 42. Global Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application (2027-2032) Table 43. Global Chinese Medicine Reference Substance (CMRS) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Chinese Medicine Reference Substance (CMRS) Sales by Region (2021-2026) & (k units) Table 45. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Region (2021-2026) Table 46. Global Chinese Medicine Reference Substance (CMRS) Sales by Region (2027-2032) & (k units) Table 47. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Region (2027-2032) Table 48. Global Chinese Medicine Reference Substance (CMRS) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Chinese Medicine Reference Substance (CMRS) Sales Value Share by Region (2021-2026) Table 51. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Chinese Medicine Reference Substance (CMRS) Sales Value Share by Region (2027-2032) Table 53. Global Chinese Medicine Reference Substance (CMRS) Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Chinese Medicine Reference Substance (CMRS) Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Chinese Medicine Reference Substance (CMRS) Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2026) & (k units) Table 58. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2021-2026) Table 59. Global Chinese Medicine Reference Substance (CMRS) Sales by Country (2027-2032) & (k units) Table 60. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2027-2032) Table 61. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Chinese Medicine Reference Substance (CMRS) Sales Value Market Share by Country (2021-2026) Table 63. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Chinese Medicine Reference Substance (CMRS) Sales Value Market Share by Country (2027-2032) Table 65. Baoji Herbest Bio-Tech Company Information Table 66. Baoji Herbest Bio-Tech Business Overview Table 67. Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 69. Baoji Herbest Bio-Tech Recent Development Table 70. ChemFaces Company Information Table 71. ChemFaces Business Overview Table 72. ChemFaces Chinese Medicine Reference Substance (CMRS) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. ChemFaces Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 74. ChemFaces Recent Development Table 75. ChromaDex Company Information Table 76. ChromaDex Business Overview Table 77. ChromaDex Chinese Medicine Reference Substance (CMRS) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. ChromaDex Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 79. ChromaDex Recent Development Table 80. Diagnocine Company Information Table 81. Diagnocine Business Overview Table 82. Diagnocine Chinese Medicine Reference Substance (CMRS) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Diagnocine Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 84. Diagnocine Recent Development Table 85. PhytoLab Company Information Table 86. PhytoLab Business Overview Table 87. PhytoLab Chinese Medicine Reference Substance (CMRS) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. PhytoLab Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 89. PhytoLab Recent Development Table 90. Derick Company Information Table 91. Derick Business Overview Table 92. Derick Chinese Medicine Reference Substance (CMRS) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Derick Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 94. Derick Recent Development Table 95. Desite Company Information Table 96. Desite Business Overview Table 97. Desite Chinese Medicine Reference Substance (CMRS) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Desite Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 99. Desite Recent Development Table 100. GeLiPuBio Company Information Table 101. GeLiPuBio Business Overview Table 102. GeLiPuBio Chinese Medicine Reference Substance (CMRS) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. GeLiPuBio Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 104. GeLiPuBio Recent Development Table 105. Chengdu Must Biotechnology Company Information Table 106. Chengdu Must Biotechnology Business Overview Table 107. Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 109. Chengdu Must Biotechnology Recent Development Table 110. Purechemland Company Information Table 111. Purechemland Business Overview Table 112. Purechemland Chinese Medicine Reference Substance (CMRS) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Purechemland Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 114. Purechemland Recent Development Table 115. Nature Standard Company Information Table 116. Nature Standard Business Overview Table 117. Nature Standard Chinese Medicine Reference Substance (CMRS) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Nature Standard Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 119. Nature Standard Recent Development Table 120. RENI Pharmaceutical Technology Company Information Table 121. RENI Pharmaceutical Technology Business Overview Table 122. RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 124. RENI Pharmaceutical Technology Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Chinese Medicine Reference Substance (CMRS) Distributors List Table 128. Chinese Medicine Reference Substance (CMRS) Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Chinese Medicine Reference Substance (CMRS) Product Image Figure 2. Global Chinese Medicine Reference Substance (CMRS) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chinese Medicine Reference Substance (CMRS) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Chinese Medicine Reference Substance (CMRS) Sales (2021-2032) & (k units) Figure 5. Global Chinese Medicine Reference Substance (CMRS) Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Chinese Medicine Reference Substance (CMRS) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plant-Derived Reference Substances Image Figure 10. Mineral-Derived Reference Substances Image Figure 11. Chemically Synthesized Reference Substances Image Figure 12. Animal-Derived Reference Substances Image Figure 13. Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Chinese Medicine Reference Substance (CMRS) Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Chinese Medicine Reference Substance (CMRS) Sales Volume Share by Type (2021-2032) Figure 16. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Chinese Medicine Reference Substance (CMRS) Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type (2021-2032) Figure 19. Pharmaceutical Identification Image Figure 20. Pharmaceutical Development Image Figure 21. Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Chinese Medicine Reference Substance (CMRS) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Chinese Medicine Reference Substance (CMRS) Sales Volume Share by Application (2021-2032) Figure 24. Global Chinese Medicine Reference Substance (CMRS) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Chinese Medicine Reference Substance (CMRS) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application (2021-2032) Figure 27. Global Chinese Medicine Reference Substance (CMRS) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Chinese Medicine Reference Substance (CMRS) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Chinese Medicine Reference Substance (CMRS) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Chinese Medicine Reference Substance (CMRS) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Chinese Medicine Reference Substance (CMRS) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Chinese Medicine Reference Substance (CMRS) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Chinese Medicine Reference Substance (CMRS) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Chinese Medicine Reference Substance (CMRS) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Chinese Medicine Reference Substance (CMRS) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Chinese Medicine Reference Substance (CMRS) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Chinese Medicine Reference Substance (CMRS) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Chinese Medicine Reference Substance (CMRS) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Chinese Medicine Reference Substance (CMRS) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Plant-Derived Reference Substances
  • Mineral-Derived Reference Substances
  • Chemically Synthesized Reference Substances
  • Animal-Derived Reference Substances
Applications
  • Pharmaceutical Identification
  • Pharmaceutical Development
Companies covered
  • Baoji Herbest Bio-Tech
  • ChemFaces
  • ChromaDex
  • Diagnocine
  • PhytoLab
  • Derick
  • Desite
  • GeLiPuBio
  • Chengdu Must Biotechnology
  • Purechemland
  • Nature Standard
  • RENI Pharmaceutical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chinese Medicine Reference Substance (CMRS) Sales Value (2021-2032)
  4. 1.2.2 Global Chinese Medicine Reference Substance (CMRS) Sales Volume (2021-2032)
  5. 1.2.3 Global Chinese Medicine Reference Substance (CMRS) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Chinese Medicine Reference Substance (CMRS) Market Dynamics
  1. 2.1 Chinese Medicine Reference Substance (CMRS) Industry Trends
  2. 2.2 Chinese Medicine Reference Substance (CMRS) Industry Drivers
  3. 2.3 Chinese Medicine Reference Substance (CMRS) Industry Opportunities and Challenges
  4. 2.4 Chinese Medicine Reference Substance (CMRS) Industry Restraints
3 Chinese Medicine Reference Substance (CMRS) Market by Company
  1. 3.1 Global Chinese Medicine Reference Substance (CMRS) Company Revenue Ranking in 2025
  2. 3.2 Global Chinese Medicine Reference Substance (CMRS) Revenue by Company (2021-2026)
  3. 3.3 Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Company (2021-2026)
  4. 3.4 Global Chinese Medicine Reference Substance (CMRS) Average Price by Company (2021-2026)
  5. 3.5 Global Chinese Medicine Reference Substance (CMRS) Company Ranking (2024-2026)
  6. 3.6 Global Chinese Medicine Reference Substance (CMRS) Company Manufacturing Base and Headquarters
  7. 3.7 Global Chinese Medicine Reference Substance (CMRS) Company Product Type and Application
  8. 3.8 Global Chinese Medicine Reference Substance (CMRS) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Chinese Medicine Reference Substance (CMRS) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Chinese Medicine Reference Substance (CMRS) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Chinese Medicine Reference Substance (CMRS) Market by Type
  1. 4.1 Chinese Medicine Reference Substance (CMRS) Type Introduction
  2. 4.1.1 Plant-Derived Reference Substances
  3. 4.1.2 Mineral-Derived Reference Substances
  4. 4.1.3 Chemically Synthesized Reference Substances
  5. 4.1.4 Animal-Derived Reference Substances
  6. 4.2 Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Type
  7. 4.2.1 Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Chinese Medicine Reference Substance (CMRS) Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Type
  11. 4.3.1 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Type (2021-2032)
  13. 4.3.3 Global Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type (2021-2032)
5 Chinese Medicine Reference Substance (CMRS) Market by Application
  1. 5.1 Chinese Medicine Reference Substance (CMRS) Application Introduction
  2. 5.1.1 Pharmaceutical Identification
  3. 5.1.2 Pharmaceutical Development
  4. 5.2 Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Application
  5. 5.2.1 Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Chinese Medicine Reference Substance (CMRS) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Chinese Medicine Reference Substance (CMRS) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Application
  9. 5.3.1 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application (2021-2032)
6 Chinese Medicine Reference Substance (CMRS) Regional Sales and Value Analysis
  1. 6.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chinese Medicine Reference Substance (CMRS) Sales by Region (2021-2032)
  3. 6.2.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Region: 2021-2026
  4. 6.2.2 Global Chinese Medicine Reference Substance (CMRS) Sales by Region (2027-2032)
  5. 6.3 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Region (2027-2032)
  9. 6.5 Global Chinese Medicine Reference Substance (CMRS) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Chinese Medicine Reference Substance (CMRS) Sales Value (2021-2032)
  12. 6.6.2 North America Chinese Medicine Reference Substance (CMRS) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Chinese Medicine Reference Substance (CMRS) Sales Value (2021-2032)
  15. 6.7.2 Europe Chinese Medicine Reference Substance (CMRS) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Chinese Medicine Reference Substance (CMRS) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Chinese Medicine Reference Substance (CMRS) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Chinese Medicine Reference Substance (CMRS) Sales Value (2021-2032)
  21. 6.9.2 South America Chinese Medicine Reference Substance (CMRS) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales Value Share by Country, 2025 VS 2032
7 Chinese Medicine Reference Substance (CMRS) Country-level Sales and Value Analysis
  1. 7.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2032)
  4. 7.3.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2026)
  5. 7.3.2 Global Chinese Medicine Reference Substance (CMRS) Sales by Country (2027-2032)
  6. 7.4 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Chinese Medicine Reference Substance (CMRS) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Chinese Medicine Reference Substance (CMRS) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Chinese Medicine Reference Substance (CMRS) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Chinese Medicine Reference Substance (CMRS) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Baoji Herbest Bio-Tech
  2. 8.1.1 Baoji Herbest Bio-Tech Company Information
  3. 8.1.2 Baoji Herbest Bio-Tech Business Overview
  4. 8.1.3 Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Product Portfolio
  6. 8.1.5 Baoji Herbest Bio-Tech Recent Developments
  7. 8.2 ChemFaces
  8. 8.2.1 ChemFaces Company Information
  9. 8.2.2 ChemFaces Business Overview
  10. 8.2.3 ChemFaces Chinese Medicine Reference Substance (CMRS) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ChemFaces Chinese Medicine Reference Substance (CMRS) Product Portfolio
  12. 8.2.5 ChemFaces Recent Developments
  13. 8.3 ChromaDex
  14. 8.3.1 ChromaDex Company Information
  15. 8.3.2 ChromaDex Business Overview
  16. 8.3.3 ChromaDex Chinese Medicine Reference Substance (CMRS) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 ChromaDex Chinese Medicine Reference Substance (CMRS) Product Portfolio
  18. 8.3.5 ChromaDex Recent Developments
  19. 8.4 Diagnocine
  20. 8.4.1 Diagnocine Company Information
  21. 8.4.2 Diagnocine Business Overview
  22. 8.4.3 Diagnocine Chinese Medicine Reference Substance (CMRS) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Diagnocine Chinese Medicine Reference Substance (CMRS) Product Portfolio
  24. 8.4.5 Diagnocine Recent Developments
  25. 8.5 PhytoLab
  26. 8.5.1 PhytoLab Company Information
  27. 8.5.2 PhytoLab Business Overview
  28. 8.5.3 PhytoLab Chinese Medicine Reference Substance (CMRS) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 PhytoLab Chinese Medicine Reference Substance (CMRS) Product Portfolio
  30. 8.5.5 PhytoLab Recent Developments
  31. 8.6 Derick
  32. 8.6.1 Derick Company Information
  33. 8.6.2 Derick Business Overview
  34. 8.6.3 Derick Chinese Medicine Reference Substance (CMRS) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Derick Chinese Medicine Reference Substance (CMRS) Product Portfolio
  36. 8.6.5 Derick Recent Developments
  37. 8.7 Desite
  38. 8.7.1 Desite Company Information
  39. 8.7.2 Desite Business Overview
  40. 8.7.3 Desite Chinese Medicine Reference Substance (CMRS) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Desite Chinese Medicine Reference Substance (CMRS) Product Portfolio
  42. 8.7.5 Desite Recent Developments
  43. 8.8 GeLiPuBio
  44. 8.8.1 GeLiPuBio Company Information
  45. 8.8.2 GeLiPuBio Business Overview
  46. 8.8.3 GeLiPuBio Chinese Medicine Reference Substance (CMRS) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GeLiPuBio Chinese Medicine Reference Substance (CMRS) Product Portfolio
  48. 8.8.5 GeLiPuBio Recent Developments
  49. 8.9 Chengdu Must Biotechnology
  50. 8.9.1 Chengdu Must Biotechnology Company Information
  51. 8.9.2 Chengdu Must Biotechnology Business Overview
  52. 8.9.3 Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Product Portfolio
  54. 8.9.5 Chengdu Must Biotechnology Recent Developments
  55. 8.10 Purechemland
  56. 8.10.1 Purechemland Company Information
  57. 8.10.2 Purechemland Business Overview
  58. 8.10.3 Purechemland Chinese Medicine Reference Substance (CMRS) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Purechemland Chinese Medicine Reference Substance (CMRS) Product Portfolio
  60. 8.10.5 Purechemland Recent Developments
  61. 8.11 Nature Standard
  62. 8.11.1 Nature Standard Company Information
  63. 8.11.2 Nature Standard Business Overview
  64. 8.11.3 Nature Standard Chinese Medicine Reference Substance (CMRS) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Nature Standard Chinese Medicine Reference Substance (CMRS) Product Portfolio
  66. 8.11.5 Nature Standard Recent Developments
  67. 8.12 RENI Pharmaceutical Technology
  68. 8.12.1 RENI Pharmaceutical Technology Company Information
  69. 8.12.2 RENI Pharmaceutical Technology Business Overview
  70. 8.12.3 RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Product Portfolio
  72. 8.12.5 RENI Pharmaceutical Technology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chinese Medicine Reference Substance (CMRS) Value Chain Analysis
  2. 9.1.1 Chinese Medicine Reference Substance (CMRS) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chinese Medicine Reference Substance (CMRS) Sales Mode & Process
  6. 9.2 Chinese Medicine Reference Substance (CMRS) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chinese Medicine Reference Substance (CMRS) Distributors
  9. 9.2.3 Chinese Medicine Reference Substance (CMRS) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst